Form 483

STERISCIENCE SP Z O O Form 483, 2014-02-14

FDA issued a Form 483 to STERISCIENCE SP Z O O on 2014-02-14 with 12 public-safe observations.

483· Form 483 issuedHuman Drugs12 observations

STERISCIENCE SP Z O O · Warsaw, Poland · Issued February 14, 2014

Overview

  • 12 public-safe observations are available for this inspection.
  • 10 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Feb 2014
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Justin A Boyd

14 Feb 2014
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Justin A Boyd

14 Feb 2014
21 CFR 211.42(c)(10)(v)

Cleaning System

Cited by Justin A Boyd

14 Feb 2014
21 CFR 211.63

Equipment Design, Size and Location

Cited by Justin A Boyd

14 Feb 2014
21 CFR 211.68(b)

Computer control of master formula records

Cited by Justin A Boyd

Inspected site

SSSTERISCIENCE SP Z O OWarsaw, Poland

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.186(a)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 12 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere